carboxyamido-triazole has been researched along with trinitrobenzenesulfonic acid in 1 studies
| Studies (carboxyamido-triazole) | Trials (carboxyamido-triazole) | Recent Studies (post-2010) (carboxyamido-triazole) | Studies (trinitrobenzenesulfonic acid) | Trials (trinitrobenzenesulfonic acid) | Recent Studies (post-2010) (trinitrobenzenesulfonic acid) |
|---|---|---|---|---|---|
| 105 | 15 | 22 | 2,710 | 10 | 1,042 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Chen, W; Du, X; Guo, L; Ju, R; Li, J; Wang, Y; Ye, C; Zhang, D; Zhu, L | 1 |
1 other study(ies) available for carboxyamido-triazole and trinitrobenzenesulfonic acid
| Article | Year |
|---|---|
Therapeutic efficacy of carboxyamidotriazole on 2,4,6-trinitrobenzene sulfonic acid-induced colitis model is associated with the inhibition of NLRP3 inflammasome and NF-κB activation.
Topics: Animals; Cells, Cultured; Colitis; Colon; Cytokines; Female; Gene Expression Regulation; Humans; Inflammasomes; Inflammatory Bowel Diseases; Intestines; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Signal Transduction; Triazoles; Trinitrobenzenesulfonic Acid | 2017 |